Consumers

August 22, 2022

CVS Health and United Health Group are also reportedly among the bidders.

June 16, 2022

Legislation that would establish benefit categories for digital therapeutics has been introduced in Congress.

June 06, 2022

If biosimilar acceptance is to grow, it’s going to take a great deal of work to improve the levels of trust between payers, patients, and oncologists.

May 29, 2022

Pharmacy benefit managers can help health plans understand when to best leverage and align to biosimilars and other cost-effective treatments, argues Prime Therapeutics' Kelly McGrail-Pokuta.

March 25, 2022

In this episode of the "Meet the Board" podcast series, Briana Contreras, Managed Healthcare Executive editor, speaks with Ateev Mehrotra, a member of the MHE editorial advisory board and a professor of healthcare policy and medicine at Harvard Medical School. Mehtrotra is also a hospitalist at the Beth Israel Deaconess Medical Center in Boston. In the discussion, Contreras gets to know Mehrotra more on a personal level and picks his brain on some of his research interests including telehealth, alternative payment models and price transparency.

December 22, 2021

Patients with a variety of cancers spent much more money out of their own pocket than those in traditional plans. Some may be delaying treatment due to higher costs.

March 07, 2021

Half the health systems and 65% of doctors had no online reviews, which puts them at a disadvantage when millennials go shopping for healthcare.

July 22, 2020

MHE's Briana Contreras spoke with CEO of Scripta, Eric Levin. The two discussed the current state of the pharmacy benefit market and how the Scripta organization has been assisting its clients and their prescriptions prior to the COVID-19 pandemic and during.

July 02, 2020

Of the 87% of executives who see convergence already happening, 89% say it is accelerating—up from 21% who said the same in 2018.

April 20, 2020

How are healthcare systems addressing the shift from inpatient to observation?